Table 2.
Screening sleep and basal hormone and metabolite data.
| BL | DL | P | |
|---|---|---|---|
| Sleep starta (h:min) | 23:54 ± 00:14 | 00:18 ± 00:14 | 0.1 |
| Sleep enda (h:min) | 07:21 ± 00:10 | 07:35 ± 00:09 | 0.1 |
| Sleep durationa (h) | 06:37 ± 00:16 | 06:24 ± 00:14 | 0.5 |
| % Sleep efficiencya | 81.9 ± 2.8 | 78.06 ± 3.5 | 0.4 |
| Sleep latencya (h:min) | 00:35 ± 00:12 | 00:48 ± 00:12 | 0.5 |
| Fragmentation indexa | 26.4 ± 2.9 | 28.81 ± 3.4 | 0.5 |
| Basal glucoseb (mmol/L) | 4.9 ± 0.3 | 4.8 ± 0.2 | 0.7 |
| Basal insulinb (pmol/L) | 107 ± 34 | 105 ± 28 | 0.9 |
| Basal NEFAsb (mmol/L) | 0.75 ± 0.1 | 0.91 ± 0.1 | 0.07 |
| Basal TAGsb (mmol/L) | 1.1 ± 0.1 | 1.2 ± 0.2 | 0.4 |
| Basal melatoninb (pg/mL) | 1.8 ± 0.4 | 2.6 ± 0.6 | 0.05 |
Values are mean ± s.e.m. Sleep parameters n = 15 hormone and metabolic basal data n = 17.
Values are obtained from 7 days prior to BL and DL sessions. bValues represented the basal samples (T = −360 min) from each clinical session. Sleep parameters were analysed based on data obtained from sleep diaries and Actiwatch data. *P < 0.05.
This work is licensed under a